Internal Limiting Membrane Peeling as Prophylaxis of Epimacular Membrane Formation in Eyes Undergoing Vitrectomy for Rhegmatogenous Retinal Detachement
Authors:
L. Hejsek; J. Dusová; A. Stepanov; P. Rozsíval
Published in the journal:
Čes. a slov. Oftal., 70, 2014, No. 3, p. 98-101
Category:
Původní práce
Tato práce byla přednesena jako přednáška na kongresu SOE 2013 v Kodani
Summary
Purpose:
Rhegmatogenous retinal detachment is a serious condition that can significantly impair visual function, even after a successful surgery. One of the complications that can significantly impair visual acuity in the postoperative period is a development of the epimacular membrane (ERM). The aim of this work is to monitor the effect of peeling of the internal limiting membrane (ILM) in the macula at the anatomical and functional results in the postoperative period, especially with regard to the development of ERM.
Methods:
Prospective study of 21 eyes, which underwent peeling of ILM during pars plana vitrectomy for rhegmatogenous retinal detachment (on detached macula). The ILM peeling was done without using decalin during this procedure. We tested best corrected visual acuity (BCVA) and followed fundus biomicroscopic findings. Proliferative vitreoretinopathy (PVR) was evaluated according to the recommendations of the Retina Society Terminology Committee. To exclude the development of ERM in the macula optical coherence tomography (OCT) was performed at the end of the 18-month follow-up period.
Results:
In total, the results of 21 eyes of 21 patients who underwent PPV for rhegmatogenous retinal detachment were evaluated. In all of them was during PPV performed ILM peeling on detached macula, these are followed prospectively. ILM peeling without using decalin was sufficient in all eyes. All eyes with ILM peeling did not develop ERM at the end of the follow-up period.
Conclusions:
ILM peeling during PPV for rhegmatogenous retinal detachment reduces the risk of developing secondary ERM.
Key words:
rhegmatogenous retinal detachement, epimacular membrane, peeling, internal limiting membrane, pars plana vitrectomy
Zdroje
1. Awad, D., Schrader, I., Bartok, M. et al.: Brilliant Blue G as protective agent against trypan blue toxicity in human retinal pigment epithelial cells in vitro. Graefes Arch Clin Experimental Ophthalmol, 2013; 251(7): 1735–1740.
2. Council, MD., Shah, GK., Lee, HC. et al. Visual outcomes and complications of epiretinal membrane removal secondary to rhegmatogenous retinal detachment. Ophthalmology, 2005; 112(7): 1218–1221.
3. Gale, JS., Proulx, AA., Gonder, JR. et al.: Comparison of the in vitro toxicity of indocyanine green to that of trypan blue in human retinal pigment epithelium cell cultures. Am J Ophthalmol, 2004; 138(1): 64-69.
4. Gass, JDM.: Macular dysfunction caused by epiretinal membrane contraction. In Stereoscopic Atlas of Macular Diseases: Diagnosis and Treatment. Vol 2, 4th ed. St Louis, Mo: Mosby, 1997, p. 938–950.
5. Hagler, WS., Aturaliya, U.: Macular puckers after retinal detachment surgery., Br J Ophthalmol, 1971; 55(7): 451–457.
6. Lobes, LA. Jr., Burton, TC.: The incidence of macular pucker after retinal detachment surgery. Am J Ophthalmol, 1978; 85(1): 72–77.
7. Martínez-Castillo, V., Boixadera, A., Distéfano, L. et al.: Epiretinal membrane after pars plana vitrectomy for primary pseudophakic or aphakic rhegmatogenous retinal detachment: incidence and outcomes. Retina, 2012; 32(7): 1350–1355.
8. Nakagomi, R., Goto, T., Tateno, Y. et al.: Macular Slippage After Macular Hole Surgery with Internal Limiting Membrane Perliny. Current Eye Research, 2013; 38(12): 1255–1260.
9. Odrobina, D., Bednarski, M., Cisiecki, S. et al. Internal limiting membrane peeling as prophylaxis of macular pucker formation in eyes undergoing retinectomy for severe proliferative vitreoretinopathy. Retina, 2012; 32(2): 226–231.
10. Sandali, O., El Sanharawi, M., Basli, E. et al.: Paracentral retinal holes occurring after macular surgery: incidence, clinical features, and evolution. Graefes Arch Clin Experimental Ophthalmol, 2012; 250(8): 1137–1142.
11. Uemura, A.: Development of epimacular membrane following rhegmatogenous retinal detachment surgery., Nihon Ganka Gakkai Zasshi., 1994, 98(10): 994–997.
12. Uemura, A., Ideta, H., Nagasaki, H. et al.: Macular pucker after retinal detachment surgery. Ophthalmic Surg, 1992; 23: 116–119.
13. Vitrectomy with silicone oil or perfluoropropane gas in eyes with severe proliferative vitreoretinopathy: results of a randomized clinical trial. Silicone Study report 2., Retina, 1993, 13: 278–284.
14. Vitrectomy with silicone oil or sulphur hexafluoride gas in eyes with severe proliferative vitreoretinopathy: results of a randomized clinical trial. Silicone Study report 1. Arch Ophthalmol, 1992; 110(6): 779–779.
15. Vitrectomy with silicone oil or sulphur hexafluoride gas in eyes with severe proliferative vitreoretinopathy: results of a randomized clinical trial. Silicone Study report 2., Arch Ophthalmol, 1992; 110(6): 780–791.
16. Yoshida, M., Kishi, S.: Pathogenesis of macular hole recurrence and its prevention by internal limiting membrane peeling. Retina, 2007; 27(2): 169–173.
Štítky
OftalmológiaČlánok vyšiel v časopise
Česká a slovenská oftalmologie
2014 Číslo 3
- Cyklosporin A v léčbě suchého oka − systematický přehled a metaanalýza
- Pomocné látky v roztoku latanoprostu bez konzervačních látek vyvolávají zánětlivou odpověď a cytotoxicitu u imortalizovaných lidských HCE-2 epitelových buněk rohovky
- Konzervační látka polyquaternium-1 zvyšuje cytotoxicitu a zánět spojený s NF-kappaB u epitelových buněk lidské rohovky
- Dlouhodobé výsledky lokální léčby cyklosporinem A u těžkého syndromu suchého oka s 10letou dobou sledování
- Syndrom suchého oka
Najčítanejšie v tomto čísle
- Peeling vnitřní limitující membrány na odchlípené makule jako prevence rozvoje epimakulární membrány po pars plana vitrektomii pro rhegmatogenní amoci sítnice
- Operační řešení těžkého stupně ptózy horního víčka pomocí fronto-tarzálního závěsu trubičkou z biokompatibilního PVC
- Vzácná oční manifestace u podezření na Alportův syndrom
- Konzervační činidla – denní dávka benzalkonium-chloridu v léčbě glaukomu z pohledu pacienta